Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 344 (8931), 1175-1181
- https://doi.org/10.1016/s0140-6736(94)90505-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Population-Based Clinical Trial with the SPf66 Synthetic Plasmodium falciparum Malaria Vaccine in VenezuelaThe Journal of Infectious Diseases, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- Development of an asexual blood stage malaria vaccineBlood, 1989
- How much malaria is there worldwide?Parasitology Today, 1989
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987
- Immunization of Man against Falciparum and Vivax Malaria by Use of Attenuated Sporozoites *The American Journal of Tropical Medicine and Hygiene, 1975
- Is the Acquired Homologous Immunity to P. Vivax Equally Effective against Sporozoites and Trophozoites? 1The American Journal of Tropical Medicine and Hygiene, 1936